| COMMITTEE | Accrual Last 12 Months |
Accrual Last 7 Days |
Yearly Projection (7 Days) |
Accrual Last 30 Days |
Yearly Projection (30 Days) |
Accrual Last 60 Days |
Yearly Projection (60 Days) |
|---|---|---|---|---|---|---|---|
| BREAST | 1153 | 11 | 574 | 79 | 962 | 191 | 1163 |
| ERLYTX | 83 | 2 | 104 | 11 | 134 | 18 | 110 |
| GI | 173 | 3 | 157 | 15 | 183 | 33 | 201 |
| GU | 349 | 9 | 470 | 35 | 426 | 57 | 347 |
| LEUK | 161 | 8 | 417 | 23 | 280 | 38 | 231 |
| LUNG | 199 | 3 | 157 | 20 | 244 | 30 | 183 |
| LYMPH | 410 | 8 | 417 | 42 | 511 | 92 | 560 |
| MELAN | 89 | 0 | 0 | 0 | 0 | 0 | 0 |
| MMYEL | 120 | 2 | 104 | 14 | 170 | 22 | 134 |
| MULT | 46 | 2 | 104 | 6 | 73 | 10 | 61 |
| OTHER | 56 | 1 | 52 | 3 | 37 | 6 | 37 |
| SXQOL | 2 | 0 | 0 | 2 | 24 | 2 | 12 |
| Total | 2841 | 49 | 2556 | 250 | 3044 | 499 | 3039 |
| COMMITTEE | Accrual Last 12 Months |
Accrual Last 7 Days |
Yearly Projection (7 Days) |
Accrual Last 30 Days |
Yearly Projection (30 Days) |
Accrual Last 60 Days |
Yearly Projection (60 Days) |
|---|---|---|---|---|---|---|---|
| CCD | 164 | 4 | 209 | 16 | 195 | 35 | 213 |
| ERLYTX | 8 | 1 | 52 | 1 | 12 | 2 | 12 |
| GU | 4 | 0 | 0 | 0 | 0 | 1 | 6 |
| LEUK | 625 | 5 | 261 | 53 | 645 | 108 | 657 |
| LUNG | 376 | 4 | 209 | 27 | 329 | 50 | 304 |
| OTHER | 11 | 0 | 0 | 0 | 0 | 3 | 18 |
| PEOLC | 102 | 0 | 0 | 2 | 24 | 3 | 18 |
| PREV | 244 | 7 | 365 | 29 | 353 | 52 | 317 |
| SXQOL | 636 | 8 | 417 | 46 | 560 | 108 | 657 |
| Total | 2170 | 29 | 1513 | 174 | 2118 | 362 | 2202 |
| COMMITTEE | Accrual Last 12 Months |
Accrual Last 7 Days |
Yearly Projection (7 Days) |
Accrual Last 30 Days |
Yearly Projection (30 Days) |
Accrual Last 60 Days |
Yearly Projection (60 Days) |
|---|---|---|---|---|---|---|---|
| BREAST | 1153 | 11 | 574 | 79 | 962 | 191 | 1163 |
| CCD | 164 | 4 | 209 | 16 | 195 | 35 | 213 |
| ERLYTX | 91 | 3 | 157 | 12 | 146 | 20 | 122 |
| GI | 173 | 3 | 157 | 15 | 183 | 33 | 201 |
| GU | 353 | 9 | 470 | 35 | 426 | 58 | 353 |
| LEUK | 786 | 13 | 678 | 76 | 925 | 146 | 889 |
| LUNG | 575 | 7 | 365 | 47 | 572 | 80 | 487 |
| LYMPH | 410 | 8 | 417 | 42 | 511 | 92 | 560 |
| MELAN | 89 | 0 | 0 | 0 | 0 | 0 | 0 |
| MMYEL | 120 | 2 | 104 | 14 | 170 | 22 | 134 |
| MULT | 46 | 2 | 104 | 6 | 73 | 10 | 61 |
| OTHER | 67 | 1 | 52 | 3 | 37 | 9 | 55 |
| PEOLC | 102 | 0 | 0 | 2 | 24 | 3 | 18 |
| PREV | 244 | 7 | 365 | 29 | 353 | 52 | 317 |
| SXQOL | 638 | 8 | 417 | 48 | 584 | 110 | 670 |
| Total | 5011 | 78 | 4069 | 424 | 5161 | 861 | 5243 |
| COMMITTEE | Accrual Last 12 Months |
Accrual Last 7 Days |
Yearly Projection (7 Days) |
Accrual Last 30 Days |
Yearly Projection (30 Days) |
Accrual Last 60 Days |
Yearly Projection (60 Days) |
|---|---|---|---|---|---|---|---|
| BREAST | 718 | 6 | 313 | 43 | 524 | 112 | 682 |
| ERLYTX | 50 | 0 | 0 | 7 | 85 | 13 | 79 |
| GI | 125 | 2 | 104 | 9 | 110 | 23 | 140 |
| GU | 276 | 8 | 417 | 27 | 329 | 47 | 286 |
| LEUK | 101 | 4 | 209 | 13 | 158 | 21 | 128 |
| LUNG | 127 | 1 | 52 | 13 | 158 | 22 | 134 |
| LYMPH | 268 | 6 | 313 | 31 | 377 | 64 | 390 |
| MELAN | 60 | 0 | 0 | 0 | 0 | 0 | 0 |
| MMYEL | 69 | 1 | 52 | 6 | 73 | 8 | 49 |
| MULT | 17 | 0 | 0 | 2 | 24 | 2 | 12 |
| OTHER | 55 | 0 | 0 | 2 | 24 | 5 | 30 |
| SXQOL | 2 | 0 | 0 | 2 | 24 | 2 | 12 |
| Total | 1868 | 28 | 1460 | 155 | 1886 | 319 | 1942 |
| COMMITTEE | Accrual Last 12 Months |
Accrual Last 7 Days |
Yearly Projection (7 Days) |
Accrual Last 30 Days |
Yearly Projection (30 Days) |
Accrual Last 60 Days |
Yearly Projection (60 Days) |
|---|---|---|---|---|---|---|---|
| CCD | 129 | 3 | 157 | 11 | 134 | 23 | 140 |
| ERLYTX | 8 | 1 | 52 | 1 | 12 | 2 | 12 |
| GU | 4 | 0 | 0 | 0 | 0 | 1 | 6 |
| LEUK | 277 | 2 | 104 | 28 | 341 | 49 | 298 |
| LUNG | 232 | 3 | 157 | 15 | 183 | 29 | 177 |
| OTHER | 11 | 0 | 0 | 0 | 0 | 3 | 18 |
| PEOLC | 77 | 0 | 0 | 2 | 24 | 3 | 18 |
| PREV | 242 | 5 | 261 | 27 | 329 | 50 | 304 |
| SXQOL | 463 | 5 | 261 | 29 | 353 | 75 | 457 |
| Total | 1443 | 19 | 992 | 113 | 1376 | 235 | 1430 |
| COMMITTEE | Accrual Last 12 Months |
Accrual Last 7 Days |
Yearly Projection (7 Days) |
Accrual Last 30 Days |
Yearly Projection (30 Days) |
Accrual Last 60 Days |
Yearly Projection (60 Days) |
|---|---|---|---|---|---|---|---|
| BREAST | 891 | 8 | 417 | 58 | 706 | 142 | 864 |
| CCD | 157 | 2 | 104 | 10 | 122 | 25 | 152 |
| ERLYTX | 58 | 1 | 52 | 8 | 97 | 15 | 91 |
| GI | 128 | 1 | 52 | 8 | 97 | 19 | 116 |
| GU | 309 | 6 | 313 | 29 | 353 | 49 | 298 |
| LEUK | 379 | 6 | 313 | 41 | 499 | 70 | 426 |
| LUNG | 378 | 4 | 209 | 27 | 329 | 54 | 329 |
| LYMPH | 268 | 6 | 313 | 31 | 377 | 64 | 390 |
| MELAN | 60 | 0 | 0 | 0 | 0 | 0 | 0 |
| MMYEL | 69 | 1 | 52 | 6 | 73 | 8 | 49 |
| MULT | 41 | 0 | 0 | 3 | 37 | 6 | 37 |
| OTHER | 176 | 0 | 0 | 2 | 24 | 8 | 49 |
| PEOLC | 77 | 1 | 52 | 5 | 61 | 6 | 37 |
| PREV | 242 | 5 | 261 | 27 | 329 | 50 | 304 |
| SXQOL | 465 | 5 | 261 | 31 | 377 | 77 | 469 |
| Total | 3698 | 46 | 2399 | 286 | 3481 | 593 | 3611 |
| COMMITTEE | Accrual Last 12 Months |
Accrual Last 7 Days |
Yearly Projection (7 Days) |
Accrual Last 30 Days |
Yearly Projection (30 Days) |
Accrual Last 60 Days |
Yearly Projection (60 Days) |
|---|---|---|---|---|---|---|---|
| BREAST | 967 | 9 | 470 | 73 | 889 | 166 | 1011 |
| ERLYTX | 78 | 2 | 104 | 11 | 134 | 18 | 110 |
| GI | 102 | 2 | 104 | 10 | 122 | 19 | 116 |
| GU | 241 | 7 | 365 | 28 | 341 | 46 | 280 |
| LEUK | 126 | 6 | 313 | 20 | 244 | 34 | 207 |
| LUNG | 171 | 3 | 157 | 19 | 231 | 27 | 164 |
| LYMPH | 343 | 6 | 313 | 37 | 450 | 81 | 493 |
| MMYEL | 104 | 2 | 104 | 13 | 158 | 19 | 116 |
| MULT | 46 | 2 | 104 | 6 | 73 | 10 | 61 |
| Total | 2178 | 39 | 2034 | 217 | 2642 | 420 | 2558 |
| Inst. | Accrual Last 12 Months |
Accrual Last 7 Days |
Yearly Projection (7 Days) |
Accrual Last 30 Days |
Yearly Projection (30 Days) |
Accrual Last 60 Days |
Yearly Projection (60 Days) |
|---|---|---|---|---|---|---|---|
| Member | 1962 | 29 | 1513 | 162 | 1972 | 325 | 1978 |
| AFFIL | 142 | 3 | 157 | 14 | 170 | 29 | 177 |
| CCOP/NCORP | 1207 | 15 | 783 | 92 | 1120 | 200 | 1218 |
| Non-SWOG | 1696 | 27 | 1409 | 152 | 1851 | 303 | 1845 |
| Total | 5007 | 74 | 3862 | 420 | 5113 | 857 | 5218 |
| ADMIN | STUDYID | STNAME | REGTYPE | Opened? | Open Date |
|---|---|---|---|---|---|
| CCD | S2424CD | A-PACT vs SOC for GOC communication | 1 | Y | 01-JUN-26 |
| LEUK | S2504 | Richter Trans., Untreated, R-CHOP +/- Pirto | 1 | Y | 01-JUN-26 |
| ADMIN | STUDYID | STNAME | REGTYPE | Opened? | Open Date |
|---|---|---|---|---|---|
| GU | EA8134 | Penile, Local Adv, ILND +/- Chemo or ChemoRT | 1 | E | 29-MAY-26 |
| GU | EA8134 | Penile, Local Adv, ILND +/- Chemo or ChemoRT | 2 | E | 29-MAY-26 |
| ERLYTX | SN2426 | cSCC, IC Met/Inop, Amivantamab v Cetuximab | 1 | T | 22-MAY-26 |
| SXQOL | ACCL1931 | Leuk, All Stg, Levocarnitine Prophylaxis | 1 | E | 22-MAY-26 |
| SXQOL | ACCL1931 | Leuk, All Stg, Levocarnitine Prophylaxis | 2 | E | 22-MAY-26 |
| CCD | EAQ221CD | Breast, Metastatic, Imp. Adherence | 0 | E | 05-JUN-26 |
| CCD | EAQ221CD | Breast, Metastatic, Imp. Adherence | 1 | E | 05-JUN-26 |
| MELAN | A091903 | Melan, Resected Mucosal, Adj Nivo +/- Cabo | 0 | E | 04-JUN-26 |
| MELAN | A091903 | Melan, Resected Mucosal, Adj Nivo +/- Cabo | 1 | E | 04-JUN-26 |
| ADMIN | STUDYID | STNAME | REGTYPE | Registrations |
|---|---|---|---|---|
| BREAST | S2212 | Breast, TNBC, Neoadj Chemo + Pembro | 1 | 8 |
| LUNG | LUNGMAP | NSCLC, Adv, Master | 2 | 5 |
| LEUK | MYELOMATCH | MSRP for the NCI myeloMATCH Clinical Trials | 1 | 5 |
| SXQOL | S2013 | I-CHECKIT: ICI toxicity risk prediction study | 1 | 5 |
| LYMPH | S2308 | FL, LTB, Mosunetuzumab vs Rituximab | 1 | 5 |
| PREV | A212102 | Blind Ref Set for Multicancer Early Detection | 1 | 4 |
| LUNG | LUNGMAP | NSCLC, Adv, Master | 1 | 4 |
| LEUK | S1925 | CLL/SLL, Newly Dx HR, Early vs Delayed V+O | 1 | 4 |
| BREAST | S2206 | Brst, Stg II-III, MP2, Neoadj Chemo +/- Durva | 1 | 4 |
| PREV | NRGCC005 | Colon,Non-AdvancedAdenomas,Colonoscopy5v10yrs | 1 | 3 |
| GU | S1802 | Pros, Stg IV, SST ± Surg/RT to Primary Tum | 1 | 3 |
| SXQOL | S2205 | ICE COMPRESS: Reduction of CIPN from Taxanes | 1 | 3 |
| GU | S2312 | Pros, MCRPC, Cab +/- Carb | 2 | 3 |
| CCD | S2417CD | Colrec Surv, Follow-up w/ CTAC site | 1 | 3 |